Literature DB >> 22203735

Increased angiotensin II-induced hypertension and inflammatory cytokines in mice lacking angiotensin-converting enzyme N domain activity.

Frank S Ong1, Chentao X Lin, Duncan J Campbell, Derick Okwan-Duodu, Xu Chen, Wendell-Lamar B Blackwell, Kandarp H Shah, Romer A Gonzalez-Villalobos, Xiao Z Shen, Sebastien Fuchs, Kenneth E Bernstein.   

Abstract

-Angiotensin-converting enzyme (ACE) is composed of the N- and C-terminal catalytic domains. To study the role of the ACE domains in the inflammatory response, N-knockout (KO) and C-KO mice, models lacking 1 of the 2 ACE domains, were analyzed during angiotensin II-induced hypertension. At 2 weeks, N-KO mice have systolic blood pressures that averaged 173±4.6 mm Hg, which is more than 25 mm Hg higher than the blood pressures observed in wild-type or C-KO mice (146±3.2 and 147±4.2 mm Hg). After 3 weeks, blood pressure differences between N-KO, C-KO, and wild-type were even more pronounced. Macrophages from N-KO mice have increased expression of tumor necrosis factor α after stimulation with either lipopolysaccharide (about 4-fold) or angiotensin II (about 2-fold), as compared with C-KO or wild-type mice. Inhibition of the enzyme prolyl oligopeptidase, responsible for the formation of acetyl-SerAspLysPro and other peptides, eliminated the blood pressure difference and the difference in tumor necrosis factor α expression between angiotensin II-treated N-KO and wild-type mice. However, this appears independent of acetyl-SerAspLysPro. These data establish significant differences in the inflammatory response as a function of ACE N- or C-domain catalytic activity. They also indicate a novel role of prolyl oligopeptidase in the cytokine regulation and in the blood pressure response to experimental hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203735      PMCID: PMC3266456          DOI: 10.1161/HYPERTENSIONAHA.111.180844

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.

Authors:  P A Deddish; B Marcic; H L Jackman; H Z Wang; R A Skidgel; E G Erdös
Journal:  Hypertension       Date:  1998-04       Impact factor: 10.190

2.  S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase.

Authors:  H Barelli; A Petit; E Hirsch; S Wilk; G De Nanteuil; P Morain; F Checler
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

3.  Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion.

Authors:  Romer A Gonzalez-Villalobos; Sandrine Billet; Catherine Kim; Ryousuke Satou; Sebastien Fuchs; Kenneth E Bernstein; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

4.  Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids.

Authors:  F Goossens; I De Meester; G Vanhoof; S Scharpé
Journal:  Eur J Clin Chem Clin Biochem       Date:  1996-01

5.  Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

Authors:  F Soubrier; F Alhenc-Gelas; C Hubert; J Allegrini; M John; G Tregear; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Mouse angiotensin-converting enzyme is a protein composed of two homologous domains.

Authors:  K E Bernstein; B M Martin; A S Edwards; E A Bernstein
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

7.  The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme.

Authors:  A Rousseau; A Michaud; M T Chauvet; M Lenfant; P Corvol
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

8.  A mouse model of angiotensin II slow pressor response: role of oxidative stress.

Authors:  Noritaka Kawada; Enyu Imai; Alexsander Karber; William J Welch; Christopher S Wilcox
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

Authors:  L Wei; F Alhenc-Gelas; P Corvol; E Clauser
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

10.  Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.

Authors:  Sebastien Fuchs; Hong D Xiao; Justin M Cole; Jonathan W Adams; Kristen Frenzel; Annie Michaud; Hui Zhao; George Keshelava; Mario R Capecchi; Pierre Corvol; Kenneth E Bernstein
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

View more
  5 in total

Review 1.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

2.  Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.

Authors:  Hiromichi Wakui; Kouichi Tamura; Shin-Ichiro Masuda; Yuko Tsurumi-Ikeya; Megumi Fujita; Akinobu Maeda; Masato Ohsawa; Kengo Azushima; Kazushi Uneda; Miyuki Matsuda; Kenichiro Kitamura; Shinichi Uchida; Yoshiyuki Toya; Hiroyuki Kobori; Kiyotaka Nagahama; Akio Yamashita; Satoshi Umemura
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

Review 3.  Emergence and evolution of the renin-angiotensin-aldosterone system.

Authors:  David Fournier; Friedrich C Luft; Michael Bader; Detlev Ganten; Miguel A Andrade-Navarro
Journal:  J Mol Med (Berl)       Date:  2012-04-14       Impact factor: 4.599

Review 4.  Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune response.

Authors:  Kenneth E Bernstein; Zakir Khan; Jorge F Giani; Tuantuan Zhao; Masahiro Eriguchi; Ellen A Bernstein; Romer A Gonzalez-Villalobos; Xiao Z Shen
Journal:  F1000Res       Date:  2016-03-23

Review 5.  Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme.

Authors:  Romer A Gonzalez-Villalobos; Xiao Z Shen; Ellen A Bernstein; Tea Janjulia; Brian Taylor; Jorge F Giani; Wendell-Lamar B Blackwell; Kandarp H Shah; Peng D Shi; Sebastien Fuchs; Kenneth E Bernstein
Journal:  J Mol Med (Berl)       Date:  2013-05-18       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.